Form and function of our Janus faced genome
Form and function of our Janus faced genome
批准号:
8754832
负责人:
Jayakrishna Ambati
金额:
$75.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-30 至 2019-07-31
关键词:
AtlasesBiologicalBlindnessCellular biologyComplementary DNADNADefectDevelopmentDiseaseEnsureEnvironmentFaceFutureGene Expression ProfileGeneticGenomeGenomicsHeadHealthHuman GenomeInheritedLifeMediatingMetabolic PathwayMolecularNucleosidesOrganismParasitesPeripheral Nervous System DiseasesProcessPseudogenesRNARetrotransposonRetroviridaeReverse Transcriptase InhibitorsReverse TranscriptionSideToxic effectWorkfitnessgazemouse modelprevent
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project title: Form and function of our Janus faced genome
The conversion of RNA into DNA via reverse transcription has transformed the
human genome: insertion of RNA-derived DNA copies has roughly doubled the mass of
our hereditary material. However, integration of reverse transcribed RNAs is an
inefficient process, even for the most successful genomic parasites (e.g. retroviruses,
retrotransposons, and pseudogenes). The reverse transcribed copies that fail to
integrate may be considered microcosms of the Roman god Janus: with one face, they
gaze towards the past as an imperfect copy of a previous life (i.e. the RNA they are
derived from), and with another face, they look towards the future, capable of directing
the fate of their molecular environment. Remarkably, the identity and function of these
genomic misfits that lie outside the confines of the traditional landscape of DNA is largely
unexplored, but expected to be vast and powerful.
We find that endogenous cDNA formation (i.e. reverse transcribed DNA derived
from host RNA) is robust and has important biological and disease-modifying function.
Blocking reverse transcription prevents endogenous cDNA formation, and interestingly,
also blocks an endogenous cDNA-mediated mouse model of blindness. Here, we will
extend these observations to systematically analyze the host-derived reverse
transcriptome to produce the first draft atlas of the identity and function of endogenous
cDNA, in health and disease. We will also experimentally demonstrate the relevance of
endogenous cDNA to molecular and metabolic pathways, and provide an alternate
explanation of toxicity attributed nucleoside reverse transcriptase inhibitors (e.g.
peripheral neuropathy and developmental defects). We expect our work to demonstrate
that the collision of host-derived RNA and the bidirectional flow of genetic information
produces a powerful regulatory class of hereto underappreciated molecules that control
health and disease, and can be harnessed to understand and manipulate basic tenets of
cellular biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina
-
批准号:10722062
-
项目类别:
-
资助金额:$62.67万
-
财政年份:2023
-
负责人:Jayakrishna Ambati
-
依托单位:
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
-
批准号:10696066
-
项目类别:
-
资助金额:$62.08万
-
财政年份:2022
-
负责人:Jayakrishna Ambati
-
依托单位:
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
-
批准号:10517678
-
项目类别:
-
资助金额:$62.08万
-
财政年份:2022
-
负责人:Jayakrishna Ambati
-
依托单位:
Nlrp3 inflammasome activation in early diabetic retinopathy - Administrative Supplement ERG Request
-
批准号:10643583
-
项目类别:
-
资助金额:$5.28万
-
财政年份:2020
-
负责人:Jayakrishna Ambati
-
依托单位:
Inflammasome-based Alzheimer's disease therapy in the context of diabetes
-
批准号:10287353
-
项目类别:
-
资助金额:$40.37万
-
财政年份:2020
-
负责人:Jayakrishna Ambati
-
依托单位:
Nlrp3 inflammasome activation in early diabetic retinopathy
-
批准号:10414049
-
项目类别:
-
资助金额:$45.86万
-
财政年份:2020
-
负责人:Jayakrishna Ambati
-
依托单位:
Nlrp3 inflammasome activation in early diabetic retinopathy
-
批准号:10626060
-
项目类别:
-
资助金额:$47.28万
-
财政年份:2020
-
负责人:Jayakrishna Ambati
-
依托单位:
Visual system and cognitive biology in normal animals versus in an animal model of Alzheimer's disease with or without diabetes treated with solo or dual inflammasome inhibitors
-
批准号:10712956
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Jayakrishna Ambati
-
依托单位:
Non-canonical inflammasome in activation in RPE degeneration
-
批准号:10338080
-
项目类别:
-
资助金额:$56.4万
-
财政年份:2019
-
负责人:Jayakrishna Ambati
-
依托单位:
Antigen-independent suppression of ocular angiogenesis via the Fc receptor
-
批准号:10003425
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2018
-
负责人:Jayakrishna Ambati
-
依托单位:
Antigen-independent suppression of ocular angiogenesis via the Fc receptor
-
批准号:9765313
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2018
-
负责人:Jayakrishna Ambati
-
依托单位:
Antigen-independent suppression of ocular angiogenesis via the Fc receptor
-
批准号:10437790
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2018
-
负责人:Jayakrishna Ambati
-
依托单位:
Antigen-independent suppression of ocular angiogenesis via the Fc receptor
-
批准号:10192726
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2018
-
负责人:Jayakrishna Ambati
-
依托单位:
Functional studies of DICER1 and Alu RNA in geographic atrophy
-
批准号:9352443
-
项目类别:
-
资助金额:$51.27万
-
财政年份:2016
-
负责人:Jayakrishna Ambati
-
依托单位:
Form and function of our Janus faced genome
-
批准号:9337472
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2014
-
负责人:Jayakrishna Ambati
-
依托单位:
Inflammasome Activation in Geographic Atrophy
-
批准号:8757790
-
项目类别:
-
资助金额:$65.71万
-
财政年份:2014
-
负责人:Jayakrishna Ambati
-
依托单位:
Inflammasome Activation in Geographic Atrophy
-
批准号:9337460
-
项目类别:
-
资助金额:$65.87万
-
财政年份:2014
-
负责人:Jayakrishna Ambati
-
依托单位:
Inflammasome Activation in Geographic Atrophy
-
批准号:8928623
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2014
-
负责人:Jayakrishna Ambati
-
依托单位:
Form and function of our Janus faced genome
-
批准号:9118243
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2014
-
负责人:Jayakrishna Ambati
-
依托单位:
Functional studies of DICER1 and Alu RNA in geographic atrophy
-
批准号:8534903
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2012
-
负责人:Jayakrishna Ambati
-
依托单位:
海外基金